Renal Cell Cancer Ajcc V7

• CLINICAL_TRIALS trial_result · 2022-06-07
  Clinical Trial Update: Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer [Phase 2]

  Phase 2 trial evaluating trebananib with or without other targeted therapies for advanced renal cell carcinoma has completed with results po…

• CLINICAL_TRIALS trial_result · 2015-05-05
  Clinical Trial Update: Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer [Phase 2]

  Phase 2 trial investigating bevacizumab, sorafenib tosylate, and temsirolimus in metastatic kidney cancer has completed with posted results.